Palvella Therapeutics, Inc. (PVLA) Financials

PVLA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 263.8 million 31.4 million
Dec. 31, 2025 59.6 million 31.6 million
Sept. 30, 2025 66.9 million 28.3 million
June 30, 2025 73.7 million 26.0 million

PVLA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -10.9 million ?
Dec. 31, 2025 -4.9 million 1.1 million
Sept. 30, 2025 -7.9 million 1.8 million
June 30, 2025 -5.4 million 1.4 million

PVLA Net Income

No data available :(

PVLA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 261.9 million 375000 -
Dec. 31, 2025 58.0 million 431000 633000
Sept. 30, 2025 63.6 million 16.0 million -
June 30, 2025 70.4 million 14.5 million -

PVLA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 13.1 million
Dec. 31, 2025 11.3 million
Sept. 30, 2025 11.1 million
June 30, 2025 11.1 million

PVLA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 9.3 million 5.5 million -
Dec. 31, 2025 - 7.1 million 4.2 million -
Sept. 30, 2025 - 6.5 million 3.6 million -
June 30, 2025 - 5.1 million 4.1 million -

PVLA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - -

PVLA

Price: $116.51

52 week price:
20.20
151.18

Earnings Per Share: -4.18 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.2 billion

Links: